Clinical Trials Sponsored by MCM Vaccines B.V.
Total 86 results
-
MCM Vaccines B.V.CompletedVirus Diseases | Bacterial Infections | Neisseria Meningitidis
-
University Hospital, BrestMCM Vaccines B.V.Completed
-
University Hospital, Gentofte, CopenhagenMCM Vaccines B.V.CompletedThe Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects (Px-Lixi)Diabetes After Total Pancreatectomy
-
MCM Vaccines B.V.Merck Sharp & Dohme LLCCompletedVirus Diseases | Bacterial Infections
-
ANRS, Emerging Infectious DiseasesMCM Vaccines B.V.Completed
-
MCM Vaccines B.V.Merck Sharp & Dohme LLCCompletedVirus Diseases | Bacterial Infections
-
Merck Sharp & Dohme LLCMCM Vaccines B.V.CompletedVirus Diseases | Bacterial Infections
-
Merck Sharp & Dohme LLCMCM Vaccines B.V.CompletedVirus Diseases | Bacterial Infections
-
ANRS, Emerging Infectious DiseasesMCM Vaccines B.V.Completed
-
Dalhousie UniversityIWK Health Centre; MCM Vaccines B.V.CompletedInfant ImmunizationsCanada
-
Vanderbilt UniversityUniversity of Pittsburgh; MCM Vaccines B.V.CompletedPediatric Solid Organ Transplant PatientsUnited States
-
Dalhousie UniversityMount Sinai Hospital, Canada; IWK Health Centre; MCM Vaccines B.V.Completed
-
MCM Vaccines B.V.Merck Sharp & Dohme LLC; Sanofi Pasteur, a Sanofi CompanyCompletedVirus Diseases | Bacterial Infections | Neisseria Meningitidis
-
Swedish Institute for Infectious Disease ControlMCM Vaccines B.V.; Statens Serum InstitutUnknownPertussis | Tetanus | DiphtheriaSweden
-
MCM Vaccines B.V.Merck Sharp & Dohme LLC; Sanofi Pasteur, a Sanofi CompanyCompleted
-
Janssen Vaccines & Prevention B.V.TerminatedRespiratory Syncytial Virus-associated Lower Respiratory Tract Disease PreventionUnited States
-
Janssen Vaccines & Prevention B.V.CompletedCOVID-19 PreventionUnited States, South Africa, Brazil
-
Janssen Vaccines & Prevention B.V.CompletedCoronavirus Disease-2019 (COVID-19) PreventionSouth Africa, Brazil, Argentina, Mexico, India
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus PreventionUnited States
-
Janssen Vaccines & Prevention B.V.CompletedInfluenza, Human Prevention | Respiratory Syncytial Viruses PreventionUnited States
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Terminated
-
Janssen Vaccines & Prevention B.V.CompletedHuman Immunodeficiency VirusThailand
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited States, Rwanda, Kenya
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial VirusCanada, United Kingdom, Spain, Brazil, Sweden, Poland, Australia, Finland
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus PreventionUnited States
-
Janssen Vaccines & Prevention B.V.CompletedA Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy AdultsCOVID-19 PreventionUnited States, Germany, Brazil, Poland, South Africa
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Tract Diseases | Respiratory Syncytial VirusesUnited States
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Viruses | Lower Respiratory Tract DiseaseUnited States, Taiwan, Thailand, Canada, Poland, United Kingdom, Brazil, Chile, New Zealand, Estonia, Finland, South Africa, Australia, China
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Janssen Vaccines & Prevention B.V.CompletedCOVID-19 PreventionUnited States, Belgium, Poland
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus Infection PreventionGermany, Spain, Belgium, Sweden, United States
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited States, Mexico, Spain, Puerto Rico, Italy, Poland, Argentina, Brazil, Peru
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Tract Infections | Respiratory Syncytial VirusesUnited Kingdom, Finland, United States
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited Kingdom, Germany, Spain, Netherlands
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed